natural glp-1 agonists Shared earlier this week: physiology and pharmacology along the #gut-brain axis As part of the JCI's Review Series on Clinical Innovation and Scientific Progress in GLP-1 Medicine, Lisa R. Beutler summarizes The Hidden Genome of Treatment:

Morton J, Mason HJ, Ritchie KA, White M

3) were consistent with poorly differentiated sarcoma, with a spindle cell pattern, high cellularity, moderate atypia, fibrillar and edematous stroma, a mitotic index of 8 per 2 mm, diffusely positive CD34, diffusely positive monoclonal H3K27me3, Sox10-, S100-, Desmin-, and Myogenin-, suggesting a possible diagnosis of MPNST, especially if there are clinical signs of NF1-type genetic comorbidity

It tells you how much peptide sits in each millilitre and, therefore, in each syringe unit

The GHRP-2 vs ipamorelin comparison is probably the most-searched question about this compound, and it deserves a rigorous, non-hyped answer

Thats enough to raise red flags on infection risk, dosing uncertainty, and injection site reactions

Can J Gastroenterol